Dolby Laboratories, Inc. DLB Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 87.4%-1.5pp | 87.9%-0.8pp | 88.1%-0.8pp | 88.5%-0.2pp | 88.9%+0.6pp | |
| Operating margin | 18.5%-2.0pp | 18.5%-2.2pp | 19.6%-0.6pp | 20.9%+4.1pp | 20.5%+5.5pp | |
| Net margin | 17.9%-1.6pp | 18%-2.0pp | 18.9%-1.7pp | 19.6%+2.8pp | 19.4%+4.4pp | |
| EBITDA margin | 25.2%-1.6pp | 25.2%-1.6pp | 26.1%-0.1pp | 27.4%+4.6pp | 26.8%+5.6pp | |
| Free cash flow margin | 22.1%-7.5pp | 28.8%-1.2pp | 32.3%+9.0pp | 32.5%+11.5pp | 29.6%+0.8pp | |
| Returns | ||||||
| Return on equity | 9.4%-0.9pp | 9.4%-1.4pp | 10%-0.8pp | 10.5%+1.6pp | 10.3%+2.3pp | |
| Return on assets | 7.5%-0.7pp | 7.6%-1.0pp | 8%-0.6pp | 8.6%+1.5pp | 8.2%+1.7pp | |
| Return on invested capital | 13.1%+0.4pp | 12.9%0.0pp | 13.9%+1.3pp | 13.4%+3.1pp | 12.7%+3.8pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Inventory turnover | 5.2×+1.0× | 5.2×+0.9× | 5×+0.9× | 4.6×+0.4× | 4.2×-0.3× | |
| Liquidity | ||||||
| Current ratio | 3×-0.1× | 3.2×+0.3× | 3.2×+0.3× | 3.4×-0.7× | 3×-0.5× | |
| Quick ratio | 2.9×0.0× | 3.1×+0.3× | 3.1×+0.3× | 3.4×-0.7× | 3×-0.5× | |
| Cash ratio | 1.4×-0.2× | 1.6×+0.3× | 1.8×+0.4× | 1.9×-0.1× | 1.6×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -1.8×+0.2× | -2×-0.4× | -2.1×-0.5× | -1.9×+0.5× | -2×+0.4× | |
| Per Share | ||||||
| Book value per share | $27.41+3.8% | $26.87+4.1% | $26.90+5.7% | $26.88+7.1% | $26.40+5.6% | |
| Valuation | ||||||
| Market capitalization | $5.74B-25.9% | $6.12B-18.1% | $6.94B-4.9% | $7.12B-6.2% | $7.74B-3.3% | |
| Enterprise value | $5.11B-27.3% | $5.43B-21.3% | $6.18B-8.6% | $6.41B-7.1% | $7.03B-4.3% | |
| Price / earnings | 23.6×-6.6× | 25.4×-3.0× | 27.2×-0.7× | 27×-8.8× | 30.2×-11.9× | |
| Price / sales | 4.2×-1.7× | 4.6×-1.1× | 5.1×-0.6× | 5.3×-0.7× | 5.9×-0.4× | |
| Price / book | 2.2×-0.8× | 2.4×-0.6× | 2.6×-0.3× | 2.7×-0.4× | 3×-0.3× | |
| EV / EBITDA | 14.8×-5.0× | 16.1×-3.5× | 17.5×-2.7× | 17.4×-6.6× | 19.8×-7.5× | |
| EV / sales | 3.7×-1.6× | 4.1×-1.2× | 4.6×-0.7× | 4.8×-0.7× | 5.3×-0.5× | |
| Free cash flow yield | 5.3%+0.2pp | 6.3%+1.0pp | 6.3%+2.2pp | 6.1%+2.7pp | 5%+0.5pp | |
| Earnings yield | 4.2%+0.9pp | 3.9%+0.4pp | 3.7%+0.1pp | 3.7%+0.9pp | 3.3%+0.9pp | |
| Dividend yield | 2.3%+0.7pp | 2.1%+0.5pp | 1.8%+0.3pp | 1.7%+0.3pp | 1.6%+0.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Dolby Laboratories, Inc.'s profit margins?
- Dolby Laboratories, Inc. (DLB) runs a 87.4% gross margin and a 18.5% operating margin, with a 17.9% net margin.
- Where do Dolby Laboratories, Inc.'s ratios come from?
- Every ratio is computed from Dolby Laboratories, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
